Volume 95, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Post-kala-azar dermal leishmaniasis (PKDL) without previous visceral leishmaniasis (VL) is a rare dermatological manifestation of infection. To date, most of the reported cases neither showed parasitological confirmation nor explained the outcome of treatment. Herein, we report three confirmed cases that were were successfully cured after miltefosine treatment.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization (WHO), 2013. Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control: Report of a Consultative Meeting, Kolkata, India, July 2–3, 2012. Geneva, Switzerland: WHO. Available at: http://apps.who.int/iris/bitstream/10665/78608/1/9789241505215_eng.pdf. Accessed October 14, 2014. [Google Scholar]
  2. Zijlstra EE, Musa AM, Khalil EAG, El Hassan IM, , 2003. Post kala-azar dermal leishmaniasis. Lancet Infect Dis 3: 8798.[Crossref] [Google Scholar]
  3. World Health Organization (WHO), 2015. Kala-Azar Elimination Program: Report of a WHO Consultation of Partners, Geneva, Switzerland, 10–11 February 2015. Geneva, Switzerland: WHO. Available at: http://apps.who.int/iris/bitstream/10665/185042/1/9789241509497_eng.pdf. Accessed February 4, 2016. [Google Scholar]
  4. el-Hassan AM, Ghalib HW, Zylstra E, Eltoum IA, Ali MS, Ahmed HM, , 1990. Post kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis. Lancet 336: 750.[Crossref] [Google Scholar]
  5. Pal D, Naskar A, Ghosh MK, , 2013. A case of miltefosine responsive pleomorphic post kala-azar dermal leishmaniasis. Braz J Infect Dis 17: 610612.[Crossref] [Google Scholar]
  6. Islam S, Kenah E, Bhuiyan MA, Rahman KM, Goodhew B, Ghalib CM, Zahid MM, Ozaki M, Rahman MW, Haque R, Luby SP, Maguire JH, Martin D, Bern C, , 2013. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh. Am J Trop Med Hyg 89: 345353.[Crossref] [Google Scholar]
  7. Rahman KM, Islam S, Rahman MW, Kenah E, Ghalib CM, Zahid MM, Maguire J, Rahman M, Haque R, Luby SP, Bern C, , 2010. Increasing incidence of post kala-azar dermal leishmaniasis in a population based study in Bangladesh. Clin Infect Dis 50: 7376.[Crossref] [Google Scholar]
  8. Vallur AC, Duthie MS, Reinhart C, Tutterrow Y, Hamano S, Bhaskar KR, Coler RN, Mondal D, Reed SG, , 2014. Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis. Clin Microbiol Infect 20: O374O383.[Crossref] [Google Scholar]
  9. Chowdhury R, Mondal D, Chowdhury V, Faria S, Alvar J, Nabi SG, Boelaert M, Dash AP, , 2014. How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data. PLoS Negl Trop Dis 8: e3020.[Crossref] [Google Scholar]
  10. Shamsuzzaman AKM, . National Guideline for Kala-azar Case Management (Draft). Kala-azar Elimination Program, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh. [Google Scholar]
  11. Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, Thomas T, Haque R, , 2010. Enhanced case detection and improved diagnosis of PKDL in a kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis 4: e832.[Crossref] [Google Scholar]
  12. Ramesh V, Kaushal H, Mishra AK, Singh R, Salotra P, , 2015. Clinico-epidemiological analysis of post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study. BMC Public Health 15: 1092.[Crossref] [Google Scholar]
  13. Ramesh V, Katara GK, Verma S, Salotra P, , 2011. Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis. Br J Dermatol 165: 411414.[Crossref] [Google Scholar]
  14. Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, Pandey K, Narain MK, Verma N, Das VNR, Berman J, Arana B, , 2013. Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomized trial. Trop Med Int Health 18: 96100.[Crossref] [Google Scholar]
  15. Sundar S, Singh A, Chakravarty J, Rai M, , 2015. Efficacy and safety of miltefosine in treatment of post kala-azar dermal leishmaniasis. ScientificWorldJournal 2015: 414378.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 23 Mar 2016
  • Accepted : 28 Aug 2016
  • Published online : 07 Dec 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error